Tobam grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 189.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 3,700 shares of the medical instruments supplier’s stock after acquiring an additional 2,423 shares during the period. Tobam’s holdings in West Pharmaceutical Services were worth $1,111,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Pitcairn Co. increased its position in West Pharmaceutical Services by 3.4% during the first quarter. Pitcairn Co. now owns 875 shares of the medical instruments supplier’s stock worth $346,000 after buying an additional 29 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of West Pharmaceutical Services by 0.7% during the 1st quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier’s stock worth $1,779,000 after purchasing an additional 31 shares during the last quarter. RFG Advisory LLC grew its holdings in shares of West Pharmaceutical Services by 2.3% during the first quarter. RFG Advisory LLC now owns 1,465 shares of the medical instruments supplier’s stock worth $580,000 after buying an additional 33 shares in the last quarter. Ballentine Partners LLC raised its position in shares of West Pharmaceutical Services by 4.7% in the second quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 33 shares during the last quarter. Finally, Wallace Advisory Group LLC lifted its stake in shares of West Pharmaceutical Services by 4.5% during the first quarter. Wallace Advisory Group LLC now owns 957 shares of the medical instruments supplier’s stock valued at $379,000 after buying an additional 41 shares during the period. 93.90% of the stock is owned by institutional investors and hedge funds.
West Pharmaceutical Services Trading Up 0.8 %
WST traded up $2.16 during trading on Thursday, hitting $288.68. The company’s stock had a trading volume of 169,156 shares, compared to its average volume of 538,096. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The stock has a market cap of $20.94 billion, a PE ratio of 37.80, a PEG ratio of 10.57 and a beta of 1.01. The firm’s 50 day moving average price is $300.79 and its 200-day moving average price is $329.87. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68.
Insider Activity at West Pharmaceutical Services
In other news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.53% of the stock is owned by insiders.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Recommended Stories
- Five stocks we like better than West Pharmaceutical Services
- What is Put Option Volume?
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What does consumer price index measure?
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- Why Are Stock Sectors Important to Successful Investing?
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Free Report).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.